Biopharma

BTVAC

Lyophilized bivalent vaccine with live attenuated viruses against Blue Tongue serotypes 1 and 4. Virus

attenuated Blue Tongue, serotype 1, strain locally isolated and multiplied on lineage cells

BHK21, minimum 103.5 DICT 50.

Attenuated Blue Tongue virus, serotype 4, strain locally isolated and multiplied on cells of

BHK21 lineage, minimum 103.5 DICT 50.

Pharmaceutical form:

Lyophilisate to be reconstituted in the corresponding diluent.

Indications:

Prevention of Blue Tongue, serotypes 1 and 4 by

active immunization of sheep and goats

Administration:

Injection of the reconstituted vaccine subcutaneously in

back of the elbow or the inner side of the thigh.

Vaccination dose: 0.5 ml.